Want to see MTD full AI Analyst Report?
Top Page
Mettler-Toledo
(NYSE:MTD)
Select Model
Select Model
Rating:73Outperform
Price Target:
$1,539.00
▲(15.96% Upside)
Action:Upgraded
Date:07/31/26
Overall score reflects strong financial performance (high margins and strong free cash flow) and supportive trend strength (price above key moving averages). These positives are tempered by balance-sheet leverage/low-equity history, a relatively high P/E valuation, and near-term earnings-call risks from tariffs and uneven organic demand despite raised EPS guidance.
Positive Factors
High and stable profitability
Sustained high gross and operating margins indicate durable pricing power and efficient cost structure across lab, industrial and inspection lines. This margin cushion supports reinvestment in R&D, service networks and product development, helping long-term competitiveness and returns.
Negative Factors
Meaningful leverage and equity volatility
Elevated debt and past negative equity reduce financial flexibility and raise refinancing and covenant risks during downturns. Leverage constrains strategic optionality (large M&A or consistent buybacks) and increases sensitivity to interest costs, affecting long-term capital allocation choices.
Read all positive and negative factors
Positive Factors
Negative Factors
High and stable profitability
Sustained high gross and operating margins indicate durable pricing power and efficient cost structure across lab, industrial and inspection lines. This margin cushion supports reinvestment in R&D, service networks and product development, helping long-term competitiveness and returns.
Read all positive factors
Mettler-Toledo Key Performance Indicators (KPIs)
Any
Revenue By Segment
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Analyzes income from different business segments, highlighting which areas drive growth and profitability, and where the company might be vulnerable or have expansion opportunities.
Data provided by:
The Fly
The FlyMettler-Toledo (MTD) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$28.62B
Dividend YieldN/A
Average Volume (3M)196.55K
Price to Earnings (P/E)31.8
Beta (1Y)0.89
Revenue Growth6.91%
EPS Growth12.43%
CountryUS
Employees18,100
SectorHealthcare
Sector Strength45
IndustryMedical - Diagnostics & Research
Share Statistics
EPS (TTM)44.54
Shares Outstanding20,207,602
10 Day Avg. Volume168,163
30 Day Avg. Volume196,546
Financial Highlights & Ratios
PEG Ratio8.96
Price to Book (P/B)-1.22K
Price to Sales (P/S)7.14
P/FCF Ratio33.86
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$1,336.90Price Target Upside0.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)46.67
Revenue Forecast (FY)$4.23B
Mettler-Toledo Business Overview & Revenue Model
Company Description
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its do...
How the Company Makes Money
Mettler-Toledo primarily makes money by selling hardware instruments and related solutions, supplemented by recurring revenue from services and consumables.
Key revenue streams:
1) Instrument and system sales (core): The largest portion of revenu...
Mettler-Toledo Earnings Call Summary
Earnings Call Date:May 07, 2026
(Q1-2026)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Positive
The call presented a generally positive but cautious picture: the company delivered solid top-line growth aided by acquisitions, achieved strong adjusted EPS growth (+9%), raised full-year EPS growth guidance (8%–10%), and highlighted durable innovation and service momentum. Offsets include tariff-induced margin pressure (≈90 bps headwind), some soft organic demand in lab and European chemical markets, customer delays tied to geopolitical uncertainty, and a cash-flow timing hit from higher tax payments. Management emphasized confidence in execution, improving pipeline activity and upside in the back half of the year, leading to a net-positive tone despite near-term headwinds.Positive Updates
Revenue Growth and Mix
Sales of $947M in Q1; local-currency sales up 3% (1% excluding acquisitions); reported USD sales +7%. Acquisitions contributed ~1.5% to growth in the quarter.
Negative Updates
Gross Margin and Tariff Headwinds
Gross margin was 58.7% in Q1, down 80 basis points year-over-year. Company cited an incremental gross tariff headwind of ~90 basis points and estimated tariffs reduced operating profit by ~4% (tariffs were a ~4% gross headwind to EPS).
Read all updates
Q1-2026 Updates
Positive
Negative
Revenue Growth and Mix
Sales of $947M in Q1; local-currency sales up 3% (1% excluding acquisitions); reported USD sales +7%. Acquisitions contributed ~1.5% to growth in the quarter.
Read all positive updates
Company Guidance
The company guided full-year 2026 local‑currency sales growth of approximately 4% (with acquisitions contributing ~1.5% in H1 and <1% for the full year) and adjusted EPS of $46.30–$46.95 (up 8%–10% versus prior year); at recent spot rates FX is estimated to be a ~2% benefit to sales and neutral to EPS. For Q2, management expects local‑currency sales of ~3% (including ~1.5% from acquisitions) and adjusted EPS of $10.70–$10.85 (up 6%–8%); Q2 currency would benefit sales ~2% and be neutral to adjusted EPS. Other guidance detail: total amortization ~ $78M (purchased intangible amortization ~ $28M pretax, ~$1.06, excluded from adjusted EPS), interest expense ~ $70M, other income ~ $25M, effective tax rate before discretes ~ 19%, free cash flow ~ $900M (≈ +5% per share), and share repurchases of $825M–$875M. Guidance assumes the February tariff rate change benefits near term but that tariffs return to prior IEEPA levels in H2, and does not include potential tariff refunds (which would be excluded from adjusted EPS and organic sales growth).Mettler-Toledo Financial Statement Overview
Summary
Income Statement
88
Very Positive
Balance Sheet
52
Neutral
Cash Flow
86
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.13B | 4.03B | 3.87B | 3.79B | 3.92B | 3.72B |
| Gross Profit | 2.45B | 2.32B | 2.25B | 2.17B | 2.24B | 2.11B |
| EBITDA | 1.30B | 1.23B | 1.22B | 1.18B | 1.24B | 1.10B |
| Net Income | 905.61M | 869.19M | 863.14M | 788.78M | 872.50M | 768.99M |
Balance Sheet | ||||||
| Total Assets | 3.67B | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B |
| Cash, Cash Equivalents and Short-Term Investments | 51.38M | 66.89M | 59.36M | 69.81M | 95.97M | 98.56M |
| Total Debt | 2.11B | 2.34B | 2.13B | 2.20B | 2.13B | 1.80B |
| Total Liabilities | 3.66B | 3.74B | 3.37B | 3.51B | 3.47B | 3.16B |
| Stockholders Equity | 12.82M | -23.64M | -126.89M | -149.94M | 24.79M | 171.42M |
Cash Flow | ||||||
| Free Cash Flow | 863.97M | 848.65M | 864.45M | 860.55M | 737.83M | 801.25M |
| Operating Cash Flow | 975.17M | 955.77M | 968.35M | 965.87M | 859.07M | 908.83M |
| Investing Cash Flow | -172.61M | -193.87M | -119.46M | -131.69M | -139.40M | -314.11M |
| Financing Cash Flow | -817.11M | -755.17M | -855.98M | -859.59M | -716.04M | -590.55M |
Mettler-Toledo Technical Analysis
Positive
1327.18
Price Trends
1231.29
Positive
1233.63
Positive
1318.50
Positive
Market Momentum
29.66
Positive
60.92
Neutral
76.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTD, the sentiment is Positive. The current price of 1327.18 is above the 20-day moving average (MA) of 1321.36, above the 50-day MA of 1231.29, and above the 200-day MA of 1318.50, indicating a bullish trend. The MACD of 29.66 indicates Positive momentum. The RSI at 60.92 is Neutral, neither overbought nor oversold. The STOCH value of 76.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MTD.
Mettler-Toledo Risk Analysis
Mettler-Toledo disclosed 29 risk factors in its most recent earnings report. Mettler-Toledo reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Mettler-Toledo Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $213.42B | 30.84 | 13.35% | 0.32% | 7.23% | 7.47% | |
74 Outperform | $25.72B | 24.42 | 14.49% | 1.46% | 9.87% | 12.51% | |
73 Outperform | $28.62B | 31.80 | 107.93% | ― | 6.91% | 12.43% | |
71 Outperform | $39.08B | 27.73 | 20.84% | 0.59% | 9.11% | 22.77% | |
69 Neutral | $37.05B | 47.88 | 8.04% | ― | 26.39% | -28.79% | |
68 Neutral | $137.07B | 34.53 | 7.66% | 0.75% | 4.56% | 19.34% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
MTD
Mettler-Toledo
1,416.30
184.42
14.97%
A
Agilent
138.37
24.45
21.46%
DHR
Danaher
194.98
-1.03
-0.53%
DGX
Quest Diagnostics
233.01
63.54
37.50%
TMO
Thermo Fisher
574.30
109.42
23.54%
WAT
Waters
377.31
91.72
32.12%
Mettler-Toledo Corporate Events
Executive/Board ChangesShareholder Meetings
Mettler-Toledo Shareholders Approve Directors and Executive Pay
Positive
May 11, 2026
At its annual meeting on May 7, 2026, Mettler-Toledo International Inc. reported that 18,545,318 of 20,248,505 eligible shares were represented, establishing a quorum for stockholder voting. Shareholders elected nine directors to one-year terms, w...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.